The lingering symptoms of post‐ COVID ‐19 condition (long‐ COVID ): a prospective cohort study
Internal Medicine Journal · 2024-02 · 54 (2) · 224-233
DOI: 10.1111/imj.16251 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Internal Medicine Journal, online erschienen am 26.11.2023. Verfasst von Stuart Tan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Physician in Trauma and Rehabilitation Medicine, Illawarra Shoalhaven Local Health District, New South Wales, Australia. Hauptthemen laut MEDLINE: Chronic Pain, COVID-19. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Longer‐term symptoms (long COVID) may be present in seemingly recovered patients for several months and can be debilitating.
Aim
To investigate the prevalence and type of symptoms in those with a prior COVID‐19 diagnosis.
Methods
This prospective, longitudinal observational study commenced in July 2020 investigating the longer‐term health impacts of COVID‐19. Participants were recruited via public health units and media publicity. Surveys were completed upon enrolment, and at 1, 3, 6 and 12 months. Outcome measures included incidence of activity limitations and symptoms against health and vaccination status, age and gender.
Results
Overall, 339 participants were recruited. At 3 months after COVID‐19, 66.8% reported symptoms, and 44.8% were still experiencing symptoms at 12 months. Fatigue was most common at every point (between 53.1% and 33.1%). Pain symptoms increased in relative prevalence over time, whereas respiratory/pulmonary‐type symptoms decreased substantially after 3 months. Females and younger people were more likely to experience symptoms in the early stages of long COVID ( P < 0.01) and those with more comorbidities in the latter stages ( P < 0.001). Vaccination showed a statistically significant protective effect against symptoms ( P < 0.01–0.001).
Conclusion
Long‐term COVID‐19 symptoms exist among recovered patients up to 12 months after contracting the virus. Fatigue is a primary contributor, while chronic pain became more problematic after 6 months. Vaccination was a factor in preventing long‐term symptoms and aiding faster recovery from symptoms. Further work exploring additional contributors to symptom prevalence would assist in developing appropriate follow‐up care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Physician in Trauma and Rehabilitation Medicine, Illawarra Shoalhaven Local Health District, New South Wales, Australia.
- Senior Staff Specialist, Wollongong Hospital, Wollongong, New South Wales, Australia.
- Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia.
- Research Central, Illawarra Shoalhaven Local Health District, Wollongong, New South Wales, Australia.
- Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, New South Wales, Australia.
ORCID-Profile: Stuart Tan, Lyndel Hewitt, Kimberley J Davis
Zitieren
APA
Tan, S., Pryor, A. J. G., Melville, G. W., Fischer, O., Hewitt, L., & Davis, K. J. (2024). The lingering symptoms of post‐ COVID ‐19 condition (long‐ COVID ): a prospective cohort study. Internal Medicine Journal, 54(2), 224-233. https://doi.org/10.1111/imj.16251
Vancouver
Tan S, Pryor AJG, Melville GW, Fischer O, Hewitt L, Davis KJ. The lingering symptoms of post‐ COVID ‐19 condition (long‐ COVID ): a prospective cohort study. Internal Medicine Journal. 2024;54(2):224-233. doi:10.1111/imj.16251
BibTeX
@article{Tan2024,
author = {Tan, Stuart and Pryor, Anna J G and Melville, Geoffrey W and Fischer, Olivia and Hewitt, Lyndel and Davis, Kimberley J},
title = {The lingering symptoms of post‐ COVID ‐19 condition (long‐ COVID ): a prospective cohort study},
journal = {Internal Medicine Journal},
year = {2024},
volume = {54},
number = {2},
pages = {224--233},
doi = {10.1111/imj.16251}
}
EUVIMED